Prescription Required.Why?
A bronchodilator that relaxes the muscles in the airways, making it easier to breathe.
An anticholinergic that blocks the effects of acetylcholine, a chemical that constricts the airways.
Treatment of reversible airway obstruction associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
Treatment of bronchospasm in asthma.
Combimist L 30s Respicaps Cap (Levosalbutamol + Ipratropium) work together to open up the airways by relaxing the muscles around the bronchi. Levosalbutamol acts on beta-2 receptors in the lungs, causing relaxation of smooth muscle, while ipratropium blocks the action of acetylcholine, which is responsible for constricting the airways.
Store the medication at room temperature, protected from light and moisture. Keep it out of the reach of children.
The dosage and frequency of administration will vary depending on the individual patient's needs and the severity of their condition.
It is typically inhaled using a metered-dose inhaler (MDI) or a nebulizer.
Always follow your doctor's instructions carefully.
Dry mouth
Cough
Headache
Tremor
Nausea
Increased heart rate
Paradoxical bronchospasm (rare)
Avoid alcohol consumption while using this medication, as it can increase the risk of side effects.
This medication may cause dizziness or blurred vision. It is advisable to avoid driving or operating machinery until you know how this medication affects you.
Talk to your doctor before using this medication if you are pregnant or breastfeeding. It is important to weigh the benefits of treatment against the potential risks.
This medication is not usually recommended for children under 4 years old, unless prescribed by a doctor.
Patients with kidney disease should use this medication with caution.
This medication is not expected to cause problems in patients with liver disease.
https://www.medicines.org.uk/
https://www.nhs.uk/
https://www.ema.europa.eu/
